Cardiac amyloidosis is an infiltrative cardiomyopathy characterized by the accumulation of misfolded proteins in the myocardium. Elevated myocardial T1 and T2 have been reported as a potential biomarker of disease. Cardiac Magnetic Resonance Fingerprinting (cMRF) has the potential to provide improved tissue characterization for cardiac amyloidosis through simultaneous T1 and T2 mapping. Furthermore, signal evolutions obtained by cMRF may enable improved tissue characterization. In this preliminary study of cardiac amyloidosis patients, relaxometric quantities and signal evolution data are analyzed. Myocardial T1 and T2 were elevated in patients, and linear discriminant analysis of signal evolution data suggests improved discrimination of disease.